Only two Hylomecon species, H. hylomeconoides and H. vernalis, grow in Korea. H. vernalis is widely distributed in mountainous regions of Korea, and China.
1,2 H. vernalis has been used as Chinese folk medicine for the treatment of arthritis, neuralgia, and eczema. 3 Previous phytochemical and pharmacological studies on this plant reported the isolation of several alkaloids and reported them to have antiinflammatory, antispasmodic, antimicrobial, and anti-tumoral activities. 3, 4 Column chromatographic purification of the BuOH-soluble fraction of the MeOH extract of the aerial parts of H. vernalis led to the isolation of three new megastigmane glycosides (1) (2) (3) , together with four known compounds (4) (5) (6) (7) . The structures of these new compounds were elucidated on the basis of 1D and 2D NMR spectral analyses. The structures of the known compounds were identified to be (6R, 9R)-3-oxo-α-ionyl-9-O-α-L-rhamnopyranosyl-(1"→2')-β-D-glucopyranoside (4), 5 (6R, 9R)-9-hydroxymegastigman-4-en-3-one 9-O-α-L-rhamnopyranosyl-(1"→2')-β-D-glucopyranoside (5), 5 3-hydroxy-5,6-epoxy-β-ionol-9-O-β-D-glucopyranoside (6), 6 and megastigmane-7-ene-3,5,6,9-tetraol-9-O-β-D-glucopyranoside (7) 7 by comparing their spectroscopic data with data in the literature. The isolated compounds (1-7) were tested for cytotoxicity against four human tumor cells in vitro using a sulforhodamin B bioassay.
Compound 1 was obtained as a colorless gum. C-NMR spectrum, 13 carbon signals appeared, including four methyl carbons at δ C = 31.6, 30.3, 24.7, and 20.2, two methylene carbons at δ C = 48.5, and 47.8, two oxygenated methine carbons at δ C = 76.9, and 75.6, two olefinic carbons δ C = 133.1, and 125.4, two oxygenated quaternary carbons at δ C = 91.5, and 81.0, and one quaternary carbon at δ C = 43.3. The Figure 2 ). In the HMBC spectrum, long-range correlations were observed between the following protons and carbons: H-2 and C-1, C-3; H-3 and C-1, C-5, C-6; H-4 and C-2, C-6; H-7 and C-1, C-5, C-9; H-8 and C-6, C-10; H-9 and C-7, C-1'; H-10 and C-8, C-9; H-11, H-12 and C-1, C-2, C-6; H-13 and C-4, C-5, C-6 ( Figure 2 ). These spectral data led us to conclude that the aglycone structure of 1 is 3,6-epoxy-7-megastigmene-5,9-diol, which was isolated from tobacco. 8, 9 Also, the sugar moiety appeared at δ H = 4.38 (1H, d, J = 7.5 Hz), 3.82 (1H, H COSY, and HMBC spectra revealed that 1 had the same planar structure as crotalionoside C isolated from Crotalaria zanzibarica, 11 except for the optical rotation value. The optical rotation of 1 ( : −13.0°) was almost of the same value but of opposite sign to that of crotalionoside C ( : +15.8°), which suggested that compound 1 could be a stereoisomer of crotalionoside C. The relative stereochemistry of the aglycone moiety was characterized by a NOESY experiment, which showed NOE correlations between the following proton pairs (H-2a/H-4a, and H-12; H-2b/H-4b, and H-11; H-11/H-7 and H-3) as shown in Figure 3 . The absolute configuration at C-9 was determined by application of a modified Mosher's method to be R (Figure 4) . 11 But the absolute stereochemistries at C-3, C-5 and C-6 for the ring part could not be determined. Enzymatic hydrolysis of 1 with β-glucosidase (emulsin) yielded 3,6-epoxy-7-megastigmene-5,9-diol (1a), whose C-NMR spectra, indicating that 2 has an additional D-xylopyranose moiety. 12 The coupling constant (J = 7.5 Hz) of the anomeric proton of D-xylose indicated that it was in the β-form. 12 The HMBC spectrum showed correlations between H-1' (δ H = 4.32) of the D-glucose moiety and C-9 (δ C = 77.5) of the aglycone structure, 11 and between H-1'' (δ H = 4.25) of D-xylose and C-6' (δ C = 68.8) of Dglucose (Figure 2) .
12 Enzymatic hydrolysis of 2 with hesperidinase yielded 2a. The NMR data of 2a were same to those of 1a. The sugars were confirmed to be D-glucose and D-xylose by comparison of optical rotation and GC-MS analyses. Thus, the structure of 2 was determined to be megastigmane-7-en-3,6-epoxy-5,
Compound 3 was obtained as a colorless gum. The molecular formula was determined to be C C-NMR spectrum, indicating that 3 has an L-arabinopyranose moiety instead of the D-xylopyranose moiety in 2. 13 The coupling constant (J = 6.5 Hz) of the anomeric proton of L-arabinose indicated that it was in the α-form. 13 The positions of sugar residues in 3 were established by an HMBC experiment. The HMBC spectrum showed correlations between H-1' (δ H = 4.32) of D-glucose and C-9 (δ C = 77.5) of the aglycone, 11 and between H-1'' (δ H = 4.26) of L-arabinose and C-6' (δ C = 68.5) of Dglucose (Figure 2) . 13 Enzymatic hydrolysis of 3 with hesperidinase yielded 3a. The NMR data of 3a were same to those of 1a. The sugars were confirmed as D-glucose and Larabinose by comparison of optical rotation and GC-MS analyses. Thus, the structure of 3 was determined to be megastigmane-7-en-3,6-epoxy-5,
The cytotoxic activities of the isolated compounds (1-7) were evaluated by determining their inhibitory effects on human tumor cell lines (A549, SK-OV-3, SK-MEL-2, and HCT15) in vitro using the sulforhodamine B (SRB) assay. Extraction and Isolation. The half dried aerial parts of H. vernalis Maxim (Papaveraceae) (2.6 kg) were extracted with 80% MeOH three times at room temperature. The resultant MeOH extracts (240 g) were suspended in distilled water (800 mL × 3) and then successively partitioned with nhexane, CH 2 Cl 2 , EtOAc and n-BuOH, yielding 40 g, 1 g, 3 g and 30 g, respectively. The n-BuOH soluble fraction (30 g) was chromatographed on a Diaion HP-20, eluting a gradient solvent system of 100% H 2 O and 100% MeOH to give two fractions (Fraction A-B) . Fraction B (8 g) was separated over a silica gel column (230-400 mesh, 360 g) with a solvent system of CHCl 3 /MeOH/H 2 O (15:4:0.5 -6:4:1) as the eluent to give thirteen fractions (fr. B1-B13). Fr. B4 (240 mg) was purified by preparative reversed-phase HPLC, using a solvent system of 45% MeOH to obtain 6 (22 mg) and 1 (10 mg). Fr. B5 (180 mg) was purified by preparative normalphase HPLC, using a solvent system of CHCl 3 /MeOH (7:1) to give 4 (6 mg) and 5 (7 mg). Fr. B6 (280 mg) was purified by preparative reversed-phase HPLC, using a solvent system of 53% MeOH to obtain 2 (5 mg). Fr. B7 (980 mg) was purified by preparative reversed-phase HPLC, using a solvent system of 50% MeOH to furnish 3 (5 mg). Fr. B8 (500 mg) was purified by preparative normal-phase HPLC, using a solvent system of CH 2 Cl 2 /MeOH (4:1) to obtain 7 (6 mg).
Megastigmane-7-en-3,6-epoxy-5,9-diol 9R-O-β-D-glucopyranoside (1) Table 1; 13 C-NMR (CD 3 OD, 125 MHz): see Table 1 ; HR-ESI-MS m/z = 543.2412 [M + Na] + (calcd for: 543.2412).
Megastigmane-7-en-3,6-epoxy-5, Enzymatic Hydrolysis of 1, 2 and 3 Compound 1 (1.0 mg) with 1 mL of H 2 O and 4 mg of β-glucosidase (Emulsin) was stirred at 37°C for 8 days, and then extracted with CHCl 3 three times, and the CHCl 3 extract was evaporated in vacuo. The CHCl 3 extract (0.5 mg) was purified using Silica HPLC (CHCl 3 :MeOH = 10:1) to afford an aglycone 1a as a colorless gum : 10.0° (c 0.03, MeOH), Determination of the Sugars of Compounds 2-3 Each sugar (each ca. 0.5 mg) obtained from the hydrolysis of 2-3 was dissolved in anhydrous pyridine (0.1 mL) and Lcysteine methyl ester hydrochloride (2 mg) was added. The mixture was stirred at 60 o C for 1.5 h. After the reaction mixture was dried in vacuo, the residue was trimethylsilylated with 1-trimethylsilylimidazole (0.1 mL) for 2 h. The mixture was partitioned between n-hexane and H 2 0 (0.3 mL each), and the organic layer (1 μL) was analyzed by GC-MS. 15 Identification of D-glucose, D-xylose, and L-arabinose for 2 and 3 were detected in each case by co-injection of the hydrolysate with standard silylated samples, giving single peaks at D-glucose (10. Preparation of the (R)-MTPA Ester and the (S)-MTPA Ester from 1a Compound 1a (1.0 mg), in deuterated pyridine (0.2 mL), was transferred to a clean NMR tube. (S)-(+)-α-(trifluoromethyl)phenylacetyl chloride (7 µL) was immediately added under a N 2 gas stream, and the NMR tube was permitted to stand at room temperature overnight. When the reaction was completed, it afforded the (R)-MTPA ester derivative (1b) of 1a. In the same manner as described for 1b, the (S)-MTPA ester derivative (1c) of 1a was obtain- 
